Fludarabine
Colorectal Carcinoma
City of Hope Medical CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 73/ 100
Competitive context
99 Active assets in the Colorectal Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM City of Hope Medical Center | Phase 4 | BB |
Eloxatin First Affiliated Hospital of Zhejiang University | Phase 4 | BB |
Calcium folinate pentahydrate City of Hope Medical Center | Phase 4 | BB |
Capecitabine First Affiliated Hospital of Zhejiang University | Phase 4 | BB |
Irinotecan City of Hope Medical Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →